Rituximab biosimilars: introduction into clinical practice

被引：2
|
作者：
Makita, Shinichi [1 ]
Tobinai, Kensei [1 ]
机构：
[1] Natl Canc Ctr, Dept Hematol, Chuo Ku, Tokyo 1040045, Japan
来源：
LANCET HAEMATOLOGY | 2017年 / 4卷 / 08期
关键词：
LYMPHOMA;
D O I：
10.1016/S2352-3026(17)30124-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E342 / E343
页数：2
相关论文
共 50 条
  • [31] Opportunities and challenges with biosimilars - Introduction
    Tesar, Vladimir
    KIDNEY & BLOOD PRESSURE RESEARCH, 2007, 30 : 1 - 1
  • [32] Challenges with the Introduction of Biosimilars in the US
    Stevenson, James G.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (03) : 93 - 96
  • [33] Anemia in Clinical Practice: Introduction
    Cappellini, Maria-Domenica
    Beris, Photis
    SEMINARS IN HEMATOLOGY, 2015, 52 (04) : 259 - 260
  • [34] Introduction to Sertindole in Clinical Practice
    Joseph Peuskens
    CNS Drugs, 2004, 18 : 1 - 4
  • [35] Introduction of SGRT in clinical practice
    Beer, K. T.
    TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY, 2022, 21 : 27 - 30
  • [36] Introduction to sertindole in clinical practice
    Peuskens, J
    CNS DRUGS, 2004, 18 (Suppl 2) : 1 - 4
  • [37] The preclinical development of biosimilars: introduction
    Bui, Lynne K.
    DRUG DISCOVERY TODAY, 2015, 20 : 1 - 2
  • [38] Biosimilars: Introduction, Concerns, and Opportunities
    Krull, Ira S.
    Rathore, Anurag S.
    LC GC NORTH AMERICA, 2010, 28 (08) : 598 - +
  • [39] First Rituximab Course Efficacy Profile in Clinical Practice
    Choquette, Denis
    Sauvageau, Diane
    Haraoui, Boulos
    Raynauld, Jean-Pierre
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2567 - 2568
  • [40] Strengths, weaknesses and future challenges of biosimilars' development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice
    Scavone, Cristina
    Rafanielloi, Concetta
    Berrino, Liberato
    Rossi, Francesco
    Capuano, Annalisa
    PHARMACOLOGICAL RESEARCH, 2017, 126 : 138 - 142
12345